Trial Profile
Long-Term Assessment of Treatment Outcomes With Entecavir and Lamivudine for Chronic Hepatitis B Infection in Patients Who Have Enrolled in Phase III Entecavir Trials.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Apr 2011
Price :
$35
*
At a glance
- Drugs Entecavir (Primary) ; Lamivudine (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- Sponsors Bristol-Myers Squibb
- 22 Apr 2011 New trial record